Potential anticancer activity of turmeric (Curcuma longa)

Area of Science:

• Phytochemistry
• Pharmacology
• Cancer Research

Background:

• Turmeric (Curcuma longa) is a spice with a long history of medicinal use.
• Its potential anticancer properties warrant scientific investigation.

Purpose of the Study:

• To evaluate the anticancer activity of turmeric rhizomes in vitro and in vivo.
• To identify the active constituent responsible for the observed cytotoxic effects.

Main Methods:

• In vitro studies using Chinese Hamster Ovary (CHO) cells, lymphocytes, and Dalton's lymphoma ascites cells.
• In vivo studies using a mouse model with Dalton's lymphoma ascites cells.
• Extraction and isolation of active compounds from turmeric rhizomes.

Main Results:

• Turmeric extract inhibited CHO cell growth at 0.4 mg/ml and was cytotoxic to lymphocytes and Dalton's lymphoma cells at the same concentration.
• The active compound, curcumin, exhibited cytotoxicity to lymphocytes and Dalton's lymphoma cells at 4 µg/ml.
• Both turmeric extract and curcumin demonstrated a reduction in animal tumor development in preliminary experiments.

Conclusions:

• Turmeric and its active constituent, curcumin, possess significant anticancer activity.
• Curcumin is the primary compound responsible for turmeric's cytotoxic effects against cancer cells.
• Further research into curcumin as a potential anticancer therapeutic is warranted.